Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BNIP3P4 (BCL2 interacting protein 3 pseudogene 4) is annotated as a human pseudogene, related by sequence to the functional BNIP3 gene, which is a member of the Bcl-2 protein family with an established role in apoptosis and cell death pathways. As a pseudogene, BNIP3P4 does not produce a functional protein and thus is not implicated directly in cell signaling, apoptosis, disease roles, or as a therapeutic target. Its sequence similarity to the functional BNIP3 gene suggests it arose as a genomic duplicate that has lost protein-coding capacity[5]. BNIP3, the functional gene, has broad roles in apoptosis, autophagy, and disease, but BNIP3P4 is a non-functional pseudogene, not considered a molecular target and not associated with therapeutic mechanisms[5]. There are no known drugs, mechanisms, or safety considerations linked to this pseudogene, and it is not a biomarker or disease-related target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BCL2 interacting protein 3 pseudogene 4 (BNIP3P4).